<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03283085</url>
  </required_header>
  <id_info>
    <org_study_id>SHP647-304</org_study_id>
    <secondary_id>2017-000574-11</secondary_id>
    <nct_id>NCT03283085</nct_id>
  </id_info>
  <brief_title>A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)</brief_title>
  <official_title>A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and tolerability of long-term treatment
      with SHP647 in participants with moderate to severe Ulcerative Colitis (UC) or Crohn's
      disease (CD).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 27, 2018</start_date>
  <completion_date type="Anticipated">June 3, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 3, 2025</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Severity</measure>
    <time_frame>Baseline up to 16 weeks post end of treatment (EOT) [up to 7 years]</time_frame>
    <description>An adverse event (AE) is any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. Treatment-emergent AEs (TEAEs) are defined as AEs with start dates or worsening dates at the time of or following the first exposure to investigational product. The TEAEs will be further categorized based on severity as mild (may require only minimal treatment) to severe (may require intensive therapeutic intervention).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Serious Infections</measure>
    <time_frame>Baseline up to 16 weeks post EOT (up to 7 years)</time_frame>
    <description>Number of participants with serious infections will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Significant Change in Clinical Laboratory Tests Reported as an Adverse Event</measure>
    <time_frame>Baseline up to 16 weeks post EOT (up to 7 years)</time_frame>
    <description>Clinical laboratory assessments include hematology, serum chemistry and urinalysis. Any clinically significant change in the clinical laboratory value from baseline will be recorded as an AE.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Reported as an Adverse Event</measure>
    <time_frame>Baseline up to EOT (up to 7 years)</time_frame>
    <description>12-lead ECG will be recorded. Any clinically significant change in ECG will be recorded as an AE.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Significant Change in Vital Signs Reported as an Adverse Event</measure>
    <time_frame>Baseline up to 16 weeks post EOT (up to 7 years)</time_frame>
    <description>Vital sign assessments include blood pressure, pulse, respiratory rate and temperature. Any clinically significant change in vital signs from baseline will be recorded as an AE.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants who Developed Antidrug Antibodies to SHP647</measure>
    <time_frame>Baseline up to EOT (up to 7 years)</time_frame>
    <description>Number of participants with presence of antidrug antibodies to SHP647 will be assessed.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2453</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>25 mg SHP647</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be receiving 25 milligram (mg) of SHP647 subcutaneously every 4 weeks until the drug is commercially available, the participant withdraws from the study, or the investigator or sponsor decide to withdraw the participant, or the sponsor decides to close the study. Allocation will be decided based on how the participant entered into this study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>75 mg SHP647</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be receiving 75 mg of SHP647 subcutaneously every 4 weeks until the drug is commercially available, the participant withdraws from the study, or the investigator or sponsor decide to withdraw the participant, or the sponsor decides to close the study. Allocation will be decided based on how the participant entered into this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>25 mg SHP647</intervention_name>
    <description>SHP647 sterile aqueous buffered solution will be administered in dose of 25 mg subcutaneously.</description>
    <arm_group_label>25 mg SHP647</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>75 mg SHP647</intervention_name>
    <description>SHP647 sterile aqueous buffered solution will be administered in dose of 75 mg subcutaneously.</description>
    <arm_group_label>75 mg SHP647</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants and/or their parent or legally authorized representative must have an
             understanding, ability, and willingness to fully comply with study procedures and
             restrictions.

          -  Participants must be able to voluntarily provide written, signed, and dated
             (personally or via a legally authorized representative) informed consent and/or
             assent, as applicable, to participate in the study.

        Participants with Ulcerative Colitis:

          -  Participants must have been previously enrolled in study SHP647-301, SHP647-302, or
             SHP647-303, and reached 1 of the following clinical trial milestones:

               1. Completed the Week 12 visit in induction study SHP647-301 or SHP647-302, and did
                  not achieve a clinical response. Clinical response is defined as: 1. a decrease
                  from baseline in the composite score of patient-reported symptoms using daily
                  e-diary and centrally read endoscopy of at least 2 points and at least 30 percent
                  (%), with an accompanying decrease in the subscore for rectal bleeding greater
                  than or equal to (&gt;=) 1 point or a subscore for rectal bleeding less than or
                  equal to (&lt;=) 1, or 2. a decrease from the induction study (SHP647-301 or
                  SHP647-302) baseline total Mayo score of at least 3 points and at least 30%, with
                  an accompanying decrease in the rectal bleeding subscore of at least 1 point or
                  an absolute rectal bleeding subscore of 0 or 1.

               2. Completed the Week 52 visit in maintenance study SHP647-303.

               3. Withdrew early from maintenance study SHP647-303 due to treatment failure,
                  defined by an endoscopic subscore that has increased by at least 1 point over
                  baseline in the maintenance study or a value &gt;= 2 plus an increase in clinical
                  subscore (stool frequency + rectal bleeding score) of at least 2 points.
                  Centrally read endoscopic subscores will be used to determine treatment failure.

          -  Participants receiving any treatment(s) for UC are eligible provided they have been,
             and are anticipated to be, on a stable dose for the designated period of time.

        Participants with Crohn's Disease:

          -  Participants must have been previously enrolled in study SHP647-305, SHP647-306, or
             SHP647-307, and reached 1 of the following clinical trial milestones:

               1. Completed the Week 16 visit in induction study SHP647-305 or SHP647-306, and did
                  NOT meet the efficacy criteria (clinical and/or endoscopic response/remission as
                  appropriate) for entry into maintenance study SHP647-307.

               2. Completed the Week 52 visit in maintenance study SHP647-307.

               3. Withdrew early from maintenance study SHP647-307 due to treatment failure (or
                  were considered to have failed treatment, at the time of the last visit in study
                  SHP647-307), as defined in the SHP647-307 protocol.

          -  Participants receiving any treatment(s) for CD are eligible provided they have been,
             and are anticipated to be, on a stable dose for the designated period of time.

        Exclusion Criteria:

        Participants with Ulcerative Colitis:

          -  Participants who had major protocol deviation(s) (as determined by the sponsor) in
             study SHP647-301, SHP647-302, or SHP647-303.

          -  Participants who permanently discontinued investigational product because of an AE,
             regardless of relatedness to investigational product, in study SHP647-301, SHP647-302,
             or SHP647-303.

          -  Participants who are likely to require major surgery for UC.

          -  Participants are females who became pregnant during study SHP647-301, SHP647-302, or
             SHP647-303, females who are planning to become pregnant during the study period, or
             males or females of childbearing potential not agreeing to continue using appropriate
             contraception methods through the conclusion of study participation.

          -  Male participants who are planning to donate sperm and do not agree not to do so for
             the duration of the study and through 16 weeks after last dose of investigational
             product.

          -  Participants who, in the opinion of the investigator or the sponsor, will be
             uncooperative or unable to comply with study procedures.

          -  Participants who have a newly-diagnosed malignancy or recurrence of malignancy (other
             than resected cutaneous basal cell carcinoma, squamous cell carcinoma, or carcinoma in
             situ of the uterine cervix that has been treated with no evidence of recurrence).

          -  Participants who have developed any major illness/condition or evidence of an unstable
             clinical condition (eg, renal, hepatic, hematologic, gastrointestinal [except disease
             under study], endocrine, cardiovascular, pulmonary, immunologic [eg, Felty's
             syndrome], or local active infection/infectious illness) that, in the investigator's
             judgment, will substantially increase the risk to the participant if he or she
             participates in the study.

          -  Participants with any other severe acute or chronic medical or psychiatric condition
             or laboratory or electrocardiogram (ECG) abnormality that may increase the risk
             associated with study participation or investigational product administration or may
             interfere with the interpretation of study results and, in the judgment of the
             investigator, would make the participant inappropriate for entry into this study.

          -  Participants with known exposure to Mycobacterium tuberculosis (TB) since testing at
             screening in study SHP647-301 or SHP647-302 and who have been advised to require
             treatment for latent or active disease, but who are without a generally accepted
             course of treatment.

          -  Participants who are investigational site staff members or relatives of those site
             staff members or participants who are sponsor employees directly involved in the
             conduct of the study.

          -  Participants who are participating in other investigational studies (other than
             SHP647-301, SHP647-302, or SHP647-303) or plan to participate in other investigational
             studies during long-term extension study SHP647-304.

        Participants with Crohn's Disease:

          -  Participants who had major protocol deviation(s) (as determined by the sponsor) in
             study SHP647-305, SHP647-306, or SHP647-307.

          -  Participants who permanently discontinued investigational product because of an AE,
             regardless of relatedness to investigational product, in study SHP647-305, SHP647-306,
             or SHP647-307.

          -  Participants who are likely to require major surgery for CD.

          -  Participants are females who became pregnant during study SHP647-305, SHP647-306, or
             SHP647-307, females who are planning to become pregnant during the study period, or
             males or females of childbearing potential not agreeing to continue appropriate
             contraception methods through the conclusion of study participation.

          -  Male participants who are planning to donate sperm and do not agree not to do so for
             the duration of the study and through 16 weeks after last dose of investigational
             product.

          -  Participants who, in the opinion of the investigator or the sponsor, will be
             uncooperative or unable to comply with study procedures.

          -  Participants who have a newly-diagnosed malignancy or recurrence of malignancy (other
             than resected cutaneous basal cell carcinoma, squamous cell carcinoma, or carcinoma in
             situ of the uterine cervix that has been treated with no evidence of recurrence).

          -  Participants who have developed any major illness/condition or evidence of an unstable
             clinical condition (eg, renal, hepatic, hematologic, gastrointestinal [except disease
             under study], endocrine, cardiovascular, pulmonary, immunologic [eg, Felty's
             syndrome], or local active infection/infectious illness) that, in the investigator's
             judgment, will substantially increase the risk to the participant if he or she
             participates in the study.

          -  Participants with any other severe acute or chronic medical or psychiatric condition
             or laboratory or electrocardiogram (ECG) abnormality that may increase the risk
             associated with study participation or investigational product administration or may
             interfere with the interpretation of study results and, in the judgment of the
             investigator, would make the participant inappropriate for entry into this study.

          -  Participants with known exposure to Mycobacterium tuberculosis (TB) since testing at
             screening in study SHP647-305 or SHP647-306 and who have been advised to require
             treatment for latent or active disease, but who are without a generally accepted
             course of treatment.

          -  Participants who are investigational site staff members or relatives of those site
             staff members or participants who are sponsor employees directly involved in the
             conduct of the study.

          -  Participants who are participating in other investigational studies (other than
             SHP647-305, SHP647-306, or SHP647-307) or plan to participate in other investigational
             studies during long-term extension study SHP647-304.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shire Physician</last_name>
    <role>Study Director</role>
    <affiliation>Shire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shire Contact</last_name>
    <phone>+1 866 842 5335</phone>
    <email>ClinicalTransparency@shire.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arizona Digestive Health</name>
      <address>
        <city>Sun City</city>
        <state>Arizona</state>
        <zip>85351</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chirag Trivedi</last_name>
      <phone>602-264-9100</phone>
      <email>ctrivedi@arizonadigestivehealth.com</email>
    </contact>
    <investigator>
      <last_name>Chirag Trivedi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Del Sol Research Management</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gary Gottlieb</last_name>
      <phone>520-547-3020</phone>
      <email>ggottlieb@delsolresearch.com</email>
    </contact>
    <investigator>
      <last_name>Gary Gottlieb</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kindred Medical Institute for Clinical Trials, LLC</name>
      <address>
        <city>Corona</city>
        <state>California</state>
        <zip>92879</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>M. Mazen Jamal</last_name>
      <phone>951-220-4029</phone>
      <email>mazen.md@aol.com</email>
    </contact>
    <investigator>
      <last_name>M. Mazen Jamal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brigid Boland</last_name>
      <phone>619-543-2347</phone>
      <email>bboland@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Brigid Boland</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Long Beach Healthcare System</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Lee</last_name>
      <phone>562-826-8000</phone>
      <email>robert.lee@va.gov</email>
    </contact>
    <investigator>
      <last_name>Robert Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melvin Heyman</last_name>
      <phone>415-476-0820</phone>
      <email>mel.heyman@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Melvin Heyman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alliance Medical Research LLC</name>
      <address>
        <city>Coral Springs</city>
        <state>Florida</state>
        <zip>33071</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vipin Gupta</last_name>
      <phone>954-428-2480</phone>
      <email>info@pioneerclinical.com</email>
    </contact>
    <investigator>
      <last_name>Vipin Gupta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Kerman</last_name>
      <phone>305-243-2910</phone>
    </contact>
    <investigator>
      <last_name>David Kerman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Neuroscience Solutions Inc</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Harper</last_name>
    </contact>
    <investigator>
      <last_name>Linda Harper</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Clinical Research Network</name>
      <address>
        <city>Sweetwater</city>
        <state>Florida</state>
        <zip>33172</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Sarol</last_name>
      <phone>305-702-1594</phone>
    </contact>
    <investigator>
      <last_name>Juan Sarol</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DBC Research</name>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <zip>33321</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Bender</last_name>
      <phone>954-537-2100</phone>
      <email>kbendermd@dbcresearch.com</email>
    </contact>
    <investigator>
      <last_name>Kevin Bender</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Gastroenterology Specialists, PC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Salzberg</last_name>
      <phone>678-957-0057</phone>
      <email>bruceasalzberg@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Bruce Salzberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbus Regional Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Steinbook</last_name>
      <phone>706-321-0495</phone>
      <email>newtrials@serrg.com</email>
    </contact>
    <investigator>
      <last_name>Michael Steinbook</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephen Hanauer</last_name>
      <phone>312-695-4929</phone>
      <email>shanauer@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Hanauer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Rubin</last_name>
      <phone>773-834-7414</phone>
      <email>drubin@medicine.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>David Rubin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chicago Association for Research and Education in Science - NAVREF</name>
      <address>
        <city>Hines</city>
        <state>Illinois</state>
        <zip>60141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marmy Shah</last_name>
      <phone>914-960-1653</phone>
      <email>marmy.shah@va.gov</email>
    </contact>
    <investigator>
      <last_name>Marmy Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dupage Medical Group</name>
      <address>
        <city>Oakbrook Terrace</city>
        <state>Illinois</state>
        <zip>60181</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Smith</last_name>
      <phone>630-833-0653</phone>
      <email>matthew.smith@dupagemd.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tri-State Gastroentrology Associates</name>
      <address>
        <city>Florence</city>
        <state>Kentucky</state>
        <zip>41042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Jones</last_name>
      <phone>859-594-4626</phone>
      <email>mjones-research@tsddc.com</email>
    </contact>
    <investigator>
      <last_name>Michael Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterology Associates of Hazard</name>
      <address>
        <city>Hazard</city>
        <state>Kentucky</state>
        <zip>41701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uday Shankar</last_name>
      <phone>606-439-3952</phone>
      <email>shankar.gastrohep@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Uday Shankar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chevy Chase Clinical Research</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hardi</last_name>
      <phone>301-652-5520</phone>
      <email>robert.hardi@capitaldigestivecare.com</email>
    </contact>
    <investigator>
      <last_name>Robert Hardi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tri County Endoscopy</name>
      <address>
        <city>Hollywood</city>
        <state>Maryland</state>
        <zip>20636</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anil Kankaria</last_name>
      <phone>301-373-7500</phone>
      <email>kan9600@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Anil Kankaria</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ashwin Ananthakrishnan</last_name>
      <phone>617-724-3238</phone>
      <email>aananthakrishnan@partners.org</email>
    </contact>
    <investigator>
      <last_name>Ashwin Ananthakrishnan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rohit Singhania</last_name>
      <phone>413-794-7364</phone>
      <email>rohit.singhaniamd@baystatehealth.org</email>
    </contact>
    <investigator>
      <last_name>Rohit Singhania</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Marie Houghton</last_name>
      <phone>774-442-4098</phone>
      <email>anne.foley@umassmemorial.org</email>
    </contact>
    <investigator>
      <last_name>Jean Marie Houghton</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Higgins</last_name>
      <phone>734-764-0507</phone>
      <email>phiggins@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Higgins</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Health System</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Van Norstrand</last_name>
      <phone>218-786-3985</phone>
    </contact>
    <investigator>
      <last_name>Michael Van Norstrand</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive Health Center PA</name>
      <address>
        <city>Ocean Springs</city>
        <state>Mississippi</state>
        <zip>39564</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alfred McNair, Jr.</last_name>
      <phone>228-872-7612</phone>
      <email>lbrowndhc@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Alfred McNair, Jr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Biomedical Research Foundation - NAVREF</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tarun Rai</last_name>
      <phone>816-861-4700</phone>
      <phone_ext>52475</phone_ext>
      <email>tarun.rai@va.gov</email>
    </contact>
    <investigator>
      <last_name>Tarun Rai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthew Ciorba</last_name>
      <phone>314-362-9039</phone>
      <email>mciorba@im.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Matthew Ciorba</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Friedrich, Rubin, Panella, Sapienza, and Kaplounov, LLP</name>
      <address>
        <city>Englewood</city>
        <state>New Jersey</state>
        <zip>07631</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kenneth Rubin</last_name>
      <phone>201-569-7044</phone>
      <email>scopemd@aol.com</email>
    </contact>
    <investigator>
      <last_name>Kenneth Rubin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Long Island Clinical Research Associates</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Seymour Katz</last_name>
      <phone>516-466-2340</phone>
      <email>seymour.katz@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Seymour Katz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellen Scherl</last_name>
      <phone>212-746-5077</phone>
      <email>ejs2005@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Ellen Scherl</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Clinical Research Partners LLC</name>
      <address>
        <city>Willoughby</city>
        <state>Ohio</state>
        <zip>44094</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franjo Vladic</last_name>
      <phone>440-953-1899</phone>
      <email>fvladic@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Franjo Vladic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Veteran's Research and Education Foundation - NAVREF</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohammad Madhoun</last_name>
      <phone>405-361-9482</phone>
      <email>mohammad-madhoun@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Mohammad Madhoun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny Center For Digestive Health</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandra El-Hachem</last_name>
      <phone>412-359-8900</phone>
      <email>sandra.elhachem@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Sandra El-Hachem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Veterans Research Foundation of Pittsburgh - NAVREF</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fadi Fouad Francis</last_name>
      <phone>412-360-3788</phone>
      <email>fadi.francis@va.gov</email>
    </contact>
    <investigator>
      <last_name>Fadi Fouad Francis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dawn Beaulieu</last_name>
      <phone>615-322-4643</phone>
    </contact>
    <investigator>
      <last_name>Dawn Beaulieu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Gastro</name>
      <address>
        <city>Union City</city>
        <state>Tennessee</state>
        <zip>38237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kofi Nuako</last_name>
      <email>md@conductclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Kofi Nuako</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northside Gastroenterology</name>
      <address>
        <city>Cypress</city>
        <state>Texas</state>
        <zip>77429</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayub Hussain</last_name>
    </contact>
    <investigator>
      <last_name>Ayub Hussain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kelsey Seybold Clinic</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Greg Galler</last_name>
      <phone>713-442-1223</phone>
      <email>greg.galler@kelsey-seybold.com</email>
    </contact>
    <investigator>
      <last_name>Greg Galler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manreet Kaur</last_name>
      <phone>713-798-6342</phone>
      <email>manreet.kaur@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Manreet Kaur</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Med Care</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77070</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yamini Naygandhi</last_name>
    </contact>
    <investigator>
      <last_name>Yamini Naygandhi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inquest Clinical Research/Coastal Gastroenterology Associates, PA</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Advitya Malhotra</last_name>
      <phone>281-557-2527</phone>
    </contact>
    <investigator>
      <last_name>Advitya Malhotra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Val Hansen MD</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Val Hansen</last_name>
      <phone>801-797-9315</phone>
      <email>valhansen@live.com</email>
    </contact>
    <investigator>
      <last_name>Val Hansen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Moses</last_name>
      <phone>802-847-8865</phone>
      <email>peter.moses@vtmednet.org</email>
    </contact>
    <investigator>
      <last_name>Peter Moses</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mid Atlantic Health Specialists</name>
      <address>
        <city>Galax</city>
        <state>Virginia</state>
        <zip>24333</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Benish</last_name>
      <phone>276-236-2947</phone>
      <email>rvbmd@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Robert Benish</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive Health Center at UWMC</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Timothy Zisman</last_name>
      <phone>206-598-4377</phone>
      <email>tzisman@medicine.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Timothy Zisman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Scott Lee</last_name>
      <phone>206-598-4377</phone>
      <email>scottl@medicine.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI Franciscan Digestive Care Associates</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Larson</last_name>
      <phone>253-272-8664</phone>
      <email>stevenlarson@fhshealth.org</email>
    </contact>
    <investigator>
      <last_name>Steven Larson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University Hospital</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Justin Kupec</last_name>
      <phone>304-293-4123</phone>
      <email>jkupec@hsc.wvu.edu</email>
    </contact>
    <investigator>
      <last_name>Justin Kupec</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mater Adult Hospital</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jakob Begun</last_name>
    </contact>
    <investigator>
      <last_name>Jakob Begun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.ö. Krankenhaus der Barmherzigen Brüder</name>
      <address>
        <city>St. Veit an der Glan</city>
        <state>Kärnten</state>
        <zip>9300</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hans Peter Gröchenig</last_name>
    </contact>
    <investigator>
      <last_name>Hans Peter Gröchenig</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LKH-Universitätsklinikum Klinikum Graz</name>
      <address>
        <city>Graz</city>
        <state>Steiermark</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christoph Högenauer</last_name>
    </contact>
    <investigator>
      <last_name>Christoph Högenauer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Klagenfurt Am Woerthersee</name>
      <address>
        <city>Klagenfurt am Wörthersee</city>
        <zip>9020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Markus Peck-Radosavljevic</last_name>
    </contact>
    <investigator>
      <last_name>Markus Peck-Radosavljevic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Paracelsus Medizinische Privatuniversität</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sonja Gassner</last_name>
    </contact>
    <investigator>
      <last_name>Sonja Gassner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Wels-Grieskirchen GmbH</name>
      <address>
        <city>Wels</city>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Harald Hofer</last_name>
    </contact>
    <investigator>
      <last_name>Harald Hofer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitat Wien</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Walter Reinisch</last_name>
    </contact>
    <investigator>
      <last_name>Walter Reinisch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UZ Gent</name>
      <address>
        <city>Gent</city>
        <state>Oost-Vlaanderen</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martine De Vos</last_name>
      <phone>+3293322371</phone>
      <email>martine.devos@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Martine De Vos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center Banja Luka</name>
      <address>
        <city>Banja Luka</city>
        <zip>78000</zip>
        <country>Bosnia and Herzegovina</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tatjana Barac</last_name>
      <phone>+38751342574</phone>
      <email>barac.tatjana@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tatjana Barac</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment Eurohospital</name>
      <address>
        <city>Plovdiv</city>
        <zip>4004</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Penka Akrabova</last_name>
      <phone>+359888</phone>
      <phone_ext>11</phone_ext>
      <email>akrabovap@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Penka Akrabova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montreal General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain Bitton</last_name>
      <phone>(514) 934-1934</phone>
      <email>alain.bitton@mchc.mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Alain Bitton</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario San Ignacio</name>
      <address>
        <city>Bogotá</city>
        <state>Cundinamarca</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Albis Hani de Ardila</last_name>
      <phone>+5712322118</phone>
      <email>albis.hani@javeriana.edu.co</email>
    </contact>
    <investigator>
      <last_name>Albis Hani de Ardila</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Servimed Empresa Unipersonal</name>
      <address>
        <city>Bucaramanga</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jose Plata Valdivieso</last_name>
      <phone>+5673163032851</phone>
    </contact>
    <investigator>
      <last_name>Jose Plata Valdivieso</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundación Clínica Shaio</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reinaldo Rincon Sanchez</last_name>
      <phone>+3102619871</phone>
      <email>ramrs@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Reinaldo Rincon Sanchez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundación Cardioinfantil Instituto Cardiológico</name>
      <address>
        <city>Bogotá</city>
        <zip>110131</zip>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jorge Ceballos</last_name>
      <phone>+5716672727</phone>
    </contact>
    <investigator>
      <last_name>Jorge Ceballos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Pablo Tobón Uribe</name>
      <address>
        <city>Medellin</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fabián Juliao</last_name>
      <phone>+5744459753</phone>
    </contact>
    <investigator>
      <last_name>Fabián Juliao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Klinichki Bolnicki Centar Zagreb</name>
      <address>
        <city>Zagreb</city>
        <state>Grad Zagreb</state>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marko Brinar</last_name>
    </contact>
    <investigator>
      <last_name>Marko Brinar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Karlovac</name>
      <address>
        <city>Karlovac</city>
        <state>Karlovacka Županija</state>
        <zip>47000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivana Kovacic</last_name>
    </contact>
    <investigator>
      <last_name>Ivana Kovacic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Osijek</name>
      <address>
        <city>Osijek</city>
        <zip>31000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vladimir Borzan</last_name>
      <phone>+38531511511</phone>
    </contact>
    <investigator>
      <last_name>Vladimir Borzan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Virovitica</name>
      <address>
        <city>Virovitica</city>
        <zip>33000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matko Markotic</last_name>
    </contact>
    <investigator>
      <last_name>Matko Markotic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General County Hospital Vukovar</name>
      <address>
        <city>Vukovar</city>
        <zip>32000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivan Petrosevic</last_name>
    </contact>
    <investigator>
      <last_name>Ivan Petrosevic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital Zadar</name>
      <address>
        <city>Zadar</city>
        <zip>23 000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivo Klarin</last_name>
    </contact>
    <investigator>
      <last_name>Ivo Klarin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut klinicke a experimentalni mediciny</name>
      <address>
        <city>Praha 4</city>
        <zip>140 21</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pavel Drastich</last_name>
    </contact>
    <investigator>
      <last_name>Pavel Drastich</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institut klinicke a experimentalni mediciny</name>
      <address>
        <city>Praha 4</city>
        <zip>140 21</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pavel Drastich</last_name>
      <phone>+420603869913</phone>
      <email>pavel.drastich@ikem.cz</email>
    </contact>
    <investigator>
      <last_name>Pavel Drastich</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemocnice Pardubickeho kraje, a.s. Orlickoustecka nemocnice</name>
      <address>
        <city>Usti nad Orlici</city>
        <zip>562 18</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Libor Gabalec</last_name>
    </contact>
    <investigator>
      <last_name>Libor Gabalec</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Estaing</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anthony Buisson</last_name>
    </contact>
    <investigator>
      <last_name>Anthony Buisson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille cedex</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Desreumaux</last_name>
    </contact>
    <investigator>
      <last_name>Pierre Desreumaux</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marienhospital Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Württemberg</state>
        <zip>70199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ewald Hommel</last_name>
      <phone>+4971164898873</phone>
      <email>ewald.hommel@vinzenz.de</email>
    </contact>
    <investigator>
      <last_name>Ewald Hommel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Lüneburg</name>
      <address>
        <city>Lüneburg</city>
        <state>Niedersachsen</state>
        <zip>21339</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Torsten Kucharzik</last_name>
    </contact>
    <investigator>
      <last_name>Torsten Kucharzik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastroenterologische Gemeinschaftspraxis Minden</name>
      <address>
        <city>Minden</city>
        <state>Nordrhein-Westfalen</state>
        <zip>32423</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernd Bokemeyer</last_name>
    </contact>
    <investigator>
      <last_name>Bernd Bokemeyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastro Campus Research GbR</name>
      <address>
        <city>Münster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48159</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Axel Schweitzer</last_name>
    </contact>
    <investigator>
      <last_name>Axel Schweitzer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Zimber/Brendel/Hoesl/Maintz</name>
      <address>
        <city>Nürnberg</city>
        <zip>90449</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Hoesl</last_name>
    </contact>
    <investigator>
      <last_name>Mark Hoesl</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <zip>455 00</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dimitrios Christodoulou</last_name>
      <phone>+2651007611</phone>
      <email>dchristodoulou@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dimitrios Christodoulou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Klinikai Kozpont</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>István Altorjay</last_name>
      <phone>+3652255196</phone>
      <email>altorjay@med.unideb.hu</email>
    </contact>
    <investigator>
      <last_name>István Altorjay</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bekes Megyei Kozponti Korhaz</name>
      <address>
        <city>Gyula</city>
        <zip>5700</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zoltan Gurzo</last_name>
    </contact>
    <investigator>
      <last_name>Zoltan Gurzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Vincent's University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>Dublin 4</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Glen Doherty</last_name>
      <phone>+35312214711</phone>
      <email>g.doherty@st-vincents.ie</email>
    </contact>
    <investigator>
      <last_name>Glen Doherty</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sigal Fishman</last_name>
      <phone>+97236974468</phone>
      <email>sigalf@tasmc.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Sigal Fishman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Complesso Integrato Columbus</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandro Armuzzi</last_name>
      <phone>+39063503310</phone>
      <email>alearmuzzi@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Alessandro Armuzzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Severance Hospital at Yonsei University Health System - PPDS</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jae Hee Cheon</last_name>
      <phone>+82222281990</phone>
      <email>geniushee@yuhs.ac</email>
    </contact>
    <investigator>
      <last_name>Jae Hee Cheon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klaipeda University Hospital</name>
      <address>
        <city>Klaipeda</city>
        <zip>92288</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Violeta Jakovlevaite</last_name>
      <phone>+370846396547</phone>
      <email>viletajak@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Violeta Jakovlevaite</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Investigacion Clinica Acelerada, S.C.</name>
      <address>
        <city>Distrito Federal</city>
        <zip>07020</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emilio Bermudez Villegas</last_name>
      <phone>+525557813954</phone>
      <email>emiliobermudez14@yahoo.com.mx</email>
    </contact>
    <investigator>
      <last_name>Emilio Bermudez Villegas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum Amsterdam</name>
      <address>
        <city>Amsterdam-Zuidoost</city>
        <zip>2820</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Geert D'Haens</last_name>
      <phone>+3215505011</phone>
      <email>g.dhaens@amc.uva.nl</email>
    </contact>
    <investigator>
      <last_name>Geert D'Haens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instytut Centrum Zdrowia Matki Polki</name>
      <address>
        <city>Lódz</city>
        <state>Lódzkie</state>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elzbieta Czkwianianc</last_name>
      <phone>+48422711341</phone>
      <email>kpg@iczmp.edu.pl</email>
    </contact>
    <investigator>
      <last_name>Elzbieta Czkwianianc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Braga</name>
      <address>
        <city>Braga</city>
        <zip>4710-243</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raquel Gonçalves</last_name>
      <phone>+351253027000</phone>
      <email>mraquel.goncalves@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Raquel Gonçalves</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cluj Clinical County Hospital</name>
      <address>
        <city>Cluj-Napoca</city>
        <state>Cluj</state>
        <zip>400162</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dan Lucian Dumitrascu</last_name>
      <phone>+40722756475</phone>
      <email>dan_dumitrascu@yahoo.de</email>
    </contact>
    <investigator>
      <last_name>Dan Lucian Dumitrascu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr.Carol Davila Emergency University Central Military Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>010825</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandica Bucurica</last_name>
    </contact>
    <investigator>
      <last_name>Sandica Bucurica</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Company Hepatolog, LLC</name>
      <address>
        <city>Samara</city>
        <zip>443063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Malova</last_name>
      <phone>+79033357481</phone>
      <email>alenamalova@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Elena Malova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital Center ''Bezanijska Kosa''</name>
      <address>
        <city>Belgrade</city>
        <zip>11080</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mirjana Cvetkovic</last_name>
      <phone>+381641608353</phone>
      <email>mikialeksa5@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mirjana Cvetkovic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center Nis</name>
      <address>
        <city>Nis</city>
        <zip>18000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Braca Petrovic</last_name>
    </contact>
    <investigator>
      <last_name>Braca Petrovic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fakultna nemocnica s poliklinikou F. D. Roosevelta</name>
      <address>
        <city>Banska Bystrica</city>
        <zip>975 17</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jozef Balaz</last_name>
      <phone>+421915071770</phone>
      <email>balaz@scouting.sk</email>
    </contact>
    <investigator>
      <last_name>Jozef Balaz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario del Rio Hortega</name>
      <address>
        <city>Valladolid</city>
        <zip>47012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jesus Barrio Andres</last_name>
      <phone>+34983420400</phone>
      <email>jbarrioa95@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jesus Barrio Andres</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spital Bülach AG</name>
      <address>
        <city>Bülach</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51103</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephan Böhm</last_name>
      <phone>+492217712305</phone>
      <email>stephan.boehm@spitalbuelach.ch</email>
    </contact>
    <investigator>
      <last_name>Stephan Böhm</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universität Zürich</name>
      <address>
        <city>Zürich</city>
        <state>Zürich (de)</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luc Biedermann</last_name>
      <phone>+41442551111</phone>
      <email>luc.biedermann@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Luc Biedermann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SI &quot;Dept. Clin. Hospital of Zaporizhzhia-2 Railway Station&quot; of SE &quot;Prydniprovska Zaliznytsia&quot;</name>
      <address>
        <city>Zaporizhzhia</city>
        <state>Zaporiz'ka Oblast</state>
        <zip>69104</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Viacheslav Neshta</last_name>
    </contact>
    <investigator>
      <last_name>Viacheslav Neshta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyiv Municipal Clinical Hospital #18</name>
      <address>
        <city>Kyiv</city>
        <zip>01030</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leonid Bilianskyi</last_name>
      <phone>+380442346649</phone>
      <email>bls@ua.fm</email>
    </contact>
    <investigator>
      <last_name>Leonid Bilianskyi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Shrewsbury Hospital</name>
      <address>
        <city>Shrewsbury</city>
        <state>Shropshire</state>
        <zip>SY3 8XQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeffery Butterworth</last_name>
      <phone>+441743261000</phone>
      <email>jeff.butterworth@sath.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jeffery Butterworth</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Bosnia and Herzegovina</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Croatia</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2017</study_first_submitted>
  <study_first_submitted_qc>September 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2017</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Immunosuppressants</keyword>
  <keyword>Mesalamine</keyword>
  <keyword>Ulcerative Colitis</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>Gastroenteritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

